Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Having ANCA-associated vasculitis significantly increases your risk of heart attacks, strokes, blood clots, and death compared to people without the disease.
Yes, a prior history of atrial fibrillation is linked to a higher risk of sudden cardiac death, especially in patients with heart attack or heart failure.
Yes, finerenone reduces cardiovascular death and worsening heart failure events in patients with heart failure with mildly reduced ejection fraction, based on a network…
Yes, SGLT2 inhibitors are effective for treating heart failure with mildly reduced ejection fraction, reducing heart failure hospitalizations and improving outcomes.
Yes, a history of pre-eclampsia is linked to a higher risk of later heart disease, likely due to early blood vessel damage that can be detected years after pregnancy.
Complex PCI carries a higher risk of major bleeding compared to non-complex PCI, with studies showing a 24% increased hazard for bleeding events.
ESAs reduce total heart failure hospitalizations and improve hemoglobin and exercise tolerance, but do not lower first hospitalization or mortality risk.
Going to a hospital with higher cardiac capability significantly lowers the risk of death for patients with cardiogenic shock compared to lower-tier facilities.
An IABP may improve survival chances in advanced cardiogenic shock, but results are mixed and depend on the patient's specific condition.
Yes, observational studies suggest pulmonary artery catheter use is linked to lower in-hospital mortality in cardiogenic shock, but randomized trials are lacking.
Immediate surgery does not improve outcomes for all STEMI patients with multivessel disease, and it may increase risks for those with heart failure.
For STEMI with multivessel disease, immediate and staged revascularization show similar outcomes overall, but staged may be safer in patients with heart failure or cardiogenic…
For most patients with STEMI and multivessel disease, immediate and staged revascularization have similar risks of death or heart attack, but staged may reduce the need for…
Yes, a post-hoc analysis of the AFIRE trial found that in patients with atrial fibrillation and stable CAD, lower baseline systolic blood pressure (≤126 mmHg) was linked to…
Using FFR guidance to decide on stenting reduces the need for repeat heart surgery in patients with multivessel coronary artery disease.
Adding VOM ethanol infusion to standard catheter ablation improves the chance of keeping a normal heart rhythm in persistent atrial fibrillation.
Adding rotational activity ablation to standard procedures increases the rate of sinus rhythm maintenance to 91.5% in persistent AF patients, compared to lower rates with…
Yes, the benefits of mRNA COVID-19 vaccines in preventing severe disease far outweigh the rare, usually mild risk of myocarditis, especially in young males.
Pediatric heart failure from myocarditis or MIS-C is managed by identifying immune triggers, using multimodal tests to distinguish active inflammation from chronic damage, and…
Continuous heart rate monitoring helps detect early signs of illness in premature infants with necrotizing enterocolitis, allowing for timely intervention that can improve…
Yes, early surgery significantly reduces long-term death risk in asymptomatic very severe aortic stenosis, with a 90% lower risk of cardiovascular death over 10 years.
Yes, multiple large studies show that RAS inhibitors after TAVR are associated with lower all-cause and cardiovascular mortality.
Yes, sex may influence cardiovascular death risk after TIA, but evidence is mixed; some studies show no significant difference, while others suggest women may have lower risk.
Yes, machine-learning models can predict coronary artery lesions in children with Kawasaki disease, with some achieving high accuracy (AUC up to 0.95).
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.